{"id":"acelarin","rwe":[],"tags":[],"phase":"discontinued","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"discontinued","trials":["NCT03610100","NCT02351765"],"aliases":["Code name: NUC-1031","NUC-1031"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"brandName":"Acelarin","companyId":"the-christie-nhs-foundation-trust","ecosystem":[],"mechanism":{"target":"","novelty":"","modality":"Small molecule","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"The Christie NHS Foundation Trust","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"}],"genericName":"Acelarin","indications":{"approved":[],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03610100","phase":"Phase 2","title":"A Phase III, Open Label, Multicentre Randomised Clinical Study Comparing Acelarin (NUC-1031) With Gemcitabine in Patients With Metastatic Pancreatic Carcinoma","status":"SUSPENDED","sponsor":"The Clatterbridge Cancer Centre NHS Foundation Trust","isPivotal":true,"enrollment":328,"indication":"Pancreatic Acinar Carcinoma, Pancreatic Neoplasms","completionDate":"2022-12"},{"nctId":"NCT02351765","phase":"Phase 1","title":"A Phase Ib, Multi-centre, Open-label Study of a First-in-class Nucleotide Analogue Acelarin (NUC-1031) in Combination With Cisplatin in Patients With Locally Advanced/Metastatic Biliary Tract Cancers","status":"COMPLETED","sponsor":"The Christie NHS Foundation Trust","isPivotal":false,"enrollment":21,"indication":"Biliary Tract Cancer, Gallbladder Cancer","completionDate":"2019-03"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Other"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Small molecule","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}